Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 93.90
-2.20 (-2.29%)
Nov 14, 2025, 5:00 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 462.41 million as of November 14, 2025. Its market cap has increased by 24.87% in one year.
Market Cap
462.41M
Enterprise Value
432.82M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
93.90
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 462.41M, an increase of 301.96%. That is a compound annual growth rate of 41.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 462.41M | 7.19% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.10B |
| NEUCA | 3.54B |
| Synektik Spólka Akcyjna | 2.22B |
| Voxel | 1.63B |
| Celon Pharma | 1.15B |
| Selvita | 758.08M |
| Centrum Medyczne ENEL-MED | 523.19M |
| Ryvu Therapeutics | 453.38M |